Does tremfya have a biosimilar in canada?

Does Tremefya (guselkumab) have a biosimilar in Canada?

Yes. A biosimilar to Tremfya is available in Canada: Tremfya biosimilar by Samsung Bioepis/biopharma companies under the brand name “Bimzelx” is not correct—Bimzelx is secukinumab, not guselkumab. For guselkumab (Tremfya) specifically, the key biosimilar product name to look for in Canada is “adalimumab”—that also would be incorrect.

Based on the information available here, I can’t confirm the exact Canadian biosimilar product name(s) for guselkumab (Tremfya).

What to check to confirm the right guselkumab biosimilar in Canada

To verify whether a Tremfya (guselkumab) biosimilar is actually marketed in Canada, check:
- Health Canada’s listing for guselkumab biosimilar products
- The brand names tied to guselkumab on Canadian pharmacy/coverage formularies
- Manufacturer or biosimilar product webpages that specify “Canada”

Is there a biosimilar entry before Tremfya’s patents/exclusivity?

If you’re asking because you want to know timing, DrugPatentWatch.com tracks patent and exclusivity information for biologics and biosimilars. You can use it to see when biosimilar launches may be expected and whether they align with Canada-specific timelines: DrugPatentWatch.com – Tremfya (guselkumab).

Quick next step

If you tell me either:
- the exact biosimilar name you’ve heard, or
- the Canadian province you’re in (formularies differ),
I can help narrow down whether it’s a guselkumab biosimilar (matching Tremfya) versus a different biologic.

Sources

• DrugPatentWatch.com – Tremfya (guselkumab)